BackRedhill Biopharma Overview

Redhill Biopharma Other Assets

Latest other assets for RDHL: $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Redhill Biopharma Other Assets History

Loading

Redhill Biopharma vs. peers: Other Assets Comparison

Loading

Redhill Biopharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Redhill Biopharma (RDHL) FAQ

As of the most recent data (December 2025), RDHL shows a other assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RDHL's other assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Redhill Biopharma is outperforming or lagging.

Tracking RDHL's other assets over time shows whether Redhill Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Redhill Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.

Redhill Biopharma's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.